Alka Hasani - Infectious Diseases

Author Information

A. Hasani is affiliated with the Infectious and Tropical Diseases Research Centre at Tabriz University of Medical Sciences in Tabriz, Iran. They are also connected with the Department of Microbiology, Faculty of Medicine, at the same university, and are involved with the Clinical Research Development Unit at the Sina Educational, Research and Treatment Centre, Faculty of Medicine, Tabriz University. Their work primarily focuses on infectious diseases and microbiology, contributing to the understanding and management of these health issues within the region and beyond.

Research Contributions

A. Hasani has made significant contributions to the field of infectious diseases and microbiology through a diverse range of research topics. Notably, they have explored the relationship between high-risk human papillomavirus and esophageal cancer in Iran, developed innovative booster vaccines for Mycobacterium tuberculosis, and investigated the roles of gut microbiota in colorectal cancer. Their work also delves into the mechanisms of biocide resistance in Acinetobacter baumannii, and they have contributed to understanding the genetic characterization and resistance mechanisms of this pathogen. Their research is pivotal in addressing public health challenges related to infectious diseases and antibiotic resistance.

Aliases

A. Hasani is also known by the aliases "A Hasani" and "Alka Hasani." These variations are used in different publications and databases, ensuring a wide recognition of their work across diverse platforms.

Publication and Citation Metrics

Metric	Value
Total Papers	115
Total Citations	1445
h-index	23

Publications:

Evidence of High-Risk Human Papillomavirus in Esophageal Cancer in East Azerbaijan Province, Northwest of Iran

DOI: 10.1155/2022/1099477

Year: 2022

Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis.

DOI: 10.1177/08853282221079105

Year: 2022

Roles of gut microbiota in colorectal carcinogenesis providing a perspective for early diagnosis and treatment.

DOI: 10.2174/1389201023666220307112413

Year: 2022

Effects of Gentamicin-Loaded Chitosan-ZnO Nanocomposite on Quorum-Sensing Regulation of Pseudomonas Aeruginosa

DOI: 10.1007/s12033-021-00336-5

Year: 2021

Escherichia coli and colorectal cancer: Unfolding the enigmatic relationship.

DOI: 10.2174/1389201022666210910094827

Year: 2021

The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis.

DOI: 10.1099/jmm.0.001435

Year: 2021

Biocide resistance in Acinetobacter baumannii: Appraising the Mechanisms.

DOI: 10.1016/j.jhin.2021.10.009

Year: 2021

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

DOI: 10.18502/ijm.v13i3.6388

Year: 2021

Expression of Efflux Pumps, Porins and Genotypic Insight Into the Carbapenem Resistance in Acinetobacter Baumannii

DOI: 10.21203/rs.3.rs-573246/v1

Year: 2021

Genetic characterization of extensive drug resistant Acinetobacter baumannii: an appalling impediment

DOI: 10.3897/folmed.63.e56566

Year: 2021

What Factors Influence Airborne Transmission?

Can Folate Biosynthesis Inhibition be Used Against All Pathogens?

Why is Biosecurity Important?

What are the Symptoms of Cervical Cancer?

How to ensure the reliability of RT-PCR results?

What is Streptococcus pneumoniae?

What are the Clinical Implications of the Inflammatory Response?

What are the Risks of Untreated Infections During Pregnancy?

How Do Immunodeficiency Disorders Affect the Body?

How is HSV Diagnosed?

Partnered Content Networks

Relevant Topics